Capsiacin 0.025% W/W Cream
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 0.5 % (p/p) |
Non-medicinal ingredients
Phénoxyéthanol, Isoparaffine en C13 à 14, Eau purifiée, Glycérol, Poly(propylène glycol), Huile de ricin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 1 year ; maximum: 3 years | 1 Crème | 1 Tous les jours |
| Enfants | minimum: 4 years ; maximum: 9 years | 1 Crème | 1 Tous les jours |
| Adolescentes | minimum: 9 years ; maximum: 13 years | 1 Crème | 1 Tous les jours |
| Adultes et adolescents | minimum: 13 years | 1 Crème | 1 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains involving muscles, tendons, ligaments, and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms persist and/or worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner.
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use. Headache, erythema, redness, and burning discomfort have been known to occur; in which case, discontinue use.
Product record
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80069151
- Status
- Inactive licence
- Licence date
- 4 May 2016
- Revision date
- 18 May 2022
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80069151
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Capsiacin 0.025% W/W Cream”, https://compoatlas.com/en/supplements/canada/80069151-capsiacin-0-025-w-w-cream, updated 18 May 2022.